Pancreatic neuroendocrine tumor

1 paper

Trial sponsors

Novartis Pharmaceuticals Corporation
Company2 trialsPhase 4123 people
Exelixis
Company1 trialPhase 2/3440 people
Hellenic Cooperative Oncology Group
1 trialPhase 225 people
Dana-Farber Cancer Institute
1 trialPhase 121 people

Latest

ENDO 2025 Abstract23 Oct

MON-037 GLP-1 Receptor Agonists in MEN1-Associated Glucagonoma: Exploring Glycemic Control and Tumor Stability

Case reportGLP-1 receptor agonists

ENDO 2025 Abstract23 Oct

MON-686 Incretin Therapy In Patients With Neurofibromatosis And Potential Clinical Manifestations Of Men Syndromes

Case reportInterventions